These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11922209)

  • 21. Development of a conjugate of (99m)Tc-EC with aminomethylenediphosphonate in the search for a bone tracer with fast clearance from soft tissue.
    Verbeke K; Rozenski J; Cleynhens B; Vanbilloen H; de Groot T; Weyns N; Bormans G; Verbruggen A
    Bioconjug Chem; 2002; 13(1):16-22. PubMed ID: 11792174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Labelling, control and radiopharmacological evaluation of 99mTc-adenosine 5'-diphosphate (99mTc-ADP) as tumour seeking agent.
    León AS; Rey AM; Leon ET; Savio EO; Kremer C; Lacava CJ; Nappa AN; Chiozzone RN; Campos ED
    Q J Nucl Med; 1996 Jun; 40(2):170-5. PubMed ID: 8909102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the phosphate balance on the activity distribution of 99mTc-hydroxy-methylene diphosphonate. Experimental studies in the mouse.
    Cronhjort M; Sääf M; Sjöberg HE; Schnell PO; Jacobsson H
    Acta Radiol; 1998 Jul; 39(4):427-33. PubMed ID: 9685832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats.
    Samnick S; Scheuer C; Münks S; El-Gibaly AM; Menger MD; Kirsch CM
    Nucl Med Biol; 2004 May; 31(4):511-22. PubMed ID: 15093822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric accumulation of bone seeking agent in a patient with advanced gastric cancer.
    Kim DW; Jeong HJ; Park SA; Kim CG
    J Korean Med Sci; 2007 Feb; 22(1):153-5. PubMed ID: 17297271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
    Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
    J Nucl Med; 2005 May; 46(5):794-9. PubMed ID: 15872353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 99mTc-2GAM: a tracer for renal imaging.
    Gianolli L; Dosio F; Matarrese M; Colombo F; Cutler C; Stepniak-Biniakiewicz D; Deutsch E; Savi A; Lucignani G; Fazio F
    Nucl Med Biol; 1996 Nov; 23(8):927-33. PubMed ID: 9004280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
    Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A
    J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents.
    Yang DJ; Kim CG; Schechter NR; Azhdarinia A; Yu DF; Oh CS; Bryant JL; Won JJ; Kim EE; Podoloff DA
    Radiology; 2003 Feb; 226(2):465-73. PubMed ID: 12563141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of biodistribution by local versus systemic administration of 99mTc-labeled pamidronate.
    Kumar D; Kumar V; Little DG; Howman-Giles RB; Wong E; Ali SO
    J Orthop Sci; 2006 Oct; 11(5):512-20. PubMed ID: 17013741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiopharmacokinetic data for 99mTc-ABP--a new radiopharmaceutical for bone scanning: comparison with 99mTc-MDP.
    Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina CE; Sepúlveda-Méndez J
    Nucl Med Biol; 1997 Jan; 24(1):27-33. PubMed ID: 9080472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radiopharmacokinetic and gammagraphic studies for calculating personalized dosimetry].
    Arteaga de Murphy C; Pedraza-López M; Ferro-Flores G; Montoya-Molina CE; Meléndez-Alafort L
    Rev Invest Clin; 2001; 53(3):228-34. PubMed ID: 11496710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity in the gastrointestinal tract after administration of bone-seeking radiopharmaceuticals. Experimental studies in mice.
    Cronhjort M; Jonsson C; Nilsson SO; Garmelius B; Jacobsson H
    Acta Radiol; 1996 Sep; 37(5):785-90. PubMed ID: 8915294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of Hypericum perforatum extract on in vitro labelling of blood elements with technetium-99m and on biodisponibility of sodium pertechnetate in Wistar rats].
    Santos-Filho SD; Bernardo-Filho M
    Acta Cir Bras; 2005; 20 Suppl 1():121-5. PubMed ID: 16186979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of novel (99m)Tc-labelled bisphosphonates as superior bone imaging agents.
    Qiu L; Cheng W; Lin J; Luo S; Xue L; Pan J
    Molecules; 2011 Jul; 16(8):6165-78. PubMed ID: 21788926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal studies of 99mTc-i-PIDP: a new bone imaging agent.
    Wang Y; Luo S; Lin J; Qiu L; Cheng W; Zhai H; Nan B; Ye W; Xia Y
    Appl Radiat Isot; 2011 Sep; 69(9):1169-75. PubMed ID: 21507669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 99mTc(CO)3-labeled pamidronate and alendronate for bone imaging.
    Palma E; Correia JD; Oliveira BL; Gano L; Santos IC; Santos I
    Dalton Trans; 2011 Mar; 40(12):2787-96. PubMed ID: 21301703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
    J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of trans-1,2-cyclohexyldinitrilo tetramethylene phosphonic acid and its radiolabelling with 99mTc for the detection of skeletal metastases.
    Panwar P; Chuttani K; Mishra P; Sharma R; Mondal A; Kumar Mishra A
    Nucl Med Commun; 2006 Aug; 27(8):619-26. PubMed ID: 16829762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
    Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
    Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.